GICPX
Price
$61.15
Change
+$0.59 (+0.97%)
Updated
Dec 24 closing price
RNPCX
Price
$61.51
Change
+$0.55 (+0.90%)
Updated
Dec 24 closing price
Ad is loading...

GICPX vs RNPCX

Header iconGICPX vs RNPCX Comparison
Open Charts GICPX vs RNPCXBanner chart's image
Gabelli Global Growth AAA
Price$61.15
Change+$0.59 (+0.97%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R3
Price$61.51
Change+$0.55 (+0.90%)
VolumeN/A
CapitalizationN/A
GICPX vs RNPCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GICPX vs. RNPCX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GICPX is a StrongBuy and RNPCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 144B vs. GICPX (195M). RNPCX pays higher dividends than GICPX: RNPCX (0.58) vs GICPX (0.26). GICPX was incepted earlier than RNPCX: GICPX (31 years) vs RNPCX (23 years). GICPX is a more actively managed with annual turnover of: 37.00 vs. RNPCX (17.00). RNPCX has a lower initial minimum investment than GICPX: RNPCX (250) vs GICPX (1000). GICPX annual gain was more profitable for investors over the last year : 31.52 vs. RNPCX (13.53). GICPX return over 5 years is better than : 54.63 vs. RNPCX (33.55).
GICPXRNPCXGICPX / RNPCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence31 years23 years-
Gain YTD31.06812.837242%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets195M144B0%
Annual Yield % from dividends0.260.5845%
Returns for 1 year31.5213.53233%
Returns for 3 years5.86-4.19-140%
Returns for 5 years54.6333.55163%
Returns for 10 years85.2871.03120%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MVST1.910.38
+24.84%
Microvast Holdings
NRP106.321.99
+1.91%
Natural Resource Partners LP
IT487.22-4.03
-0.82%
Gartner
OTLK1.42-0.02
-1.39%
Outlook Therapeutics
KNF102.63-3.08
-2.91%
Knife River Corp